Karen has over 24 years of commercial and strategic consulting experience in the biopharmaceutical industry. She started her career as a pharmaceutical sales representative and was promoted into increasing levels of responsibility eventually having managerial oversight for primary care and specialty sales teams across the US.
Karen moved into the Global Expanded Access arena in 2010 and has been responsible for leading the business discussions with pharma and biotech clients as they plan for early access to their innovative and life saving medicines. She has had extensive involvement in leading the strategic program initiatives for global early access programs in therapeutic areas of oncology, CNS, auto-immune and rare disease.
Karen graduated with honors and holds a BS in Biology from the University of Akron. She has been a contributor to several patient facing publications which center around obtaining early access to medicines in the US and Canada, as well as a contributor to rare disease publications on this unique topic.